A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer

Soo-Jeong NAM; Hyun-Yang YEO; Hee-Jin CHANG; Bo-Hyun KIM; Eun-Kyung HONG; Joong-Won PARK.
Cancer Research and Treatment ; : 1229-1242, 2016.
Artículo en Inglés | WPRIM | ID: wpr-109753

Documentos relacionados

  1. Combination of serum alpha-fetoprotein, PIVKA-Ⅱ and glypican-3 in diagnosis of hepatocellular carcinoma: a meta-analysis.
  2. The Glycosaminoglycan Side Chains and Modular Core Proteins of Heparan Sulphate Proteoglycans and the Varied Ways They Provide Tissue Protection by Regulating Physiological Processes and Cellular Behaviour.
  3. A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer.
  4. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
  5. A clinically feasible circulating tumor cell sorting system for monitoring the progression of advanced hepatocellular carcinoma.
  6. [Correlation between the expression profile of cytokeratin 19/glypican 3 and recurrence of hepatocellular carcinoma after interventional therapy].
  7. Inhibition of Glypican-3 Cleavage Results in Reduced Cell Proliferation in a Liver Cancer Cell Line.
  8. MRI-Based Radiomics Signature: A Potential Biomarker for Identifying Glypican 3-Positive Hepatocellular Carcinoma.
  9. Glypican shield for WNTs.
  10. Identification of HLA-A2 restricted epitopes of glypican-3 and induction of CTL responses in HLA-A2 transgenic mice.